Pioglitazone reduces angiotensin II-induced COX-2 expression through inhibition of ROS production and ET-1 transcription in vascular cells from spontaneously hypertensive rats

dc.contributor.authorPérez-Girón, José V
dc.contributor.authorPalacios-Ramírez, R
dc.contributor.authorMartín, Ángela
dc.contributor.authorHernanz, Raquel
dc.contributor.authorAguado, Andrea
dc.contributor.authorMartínez-Revelles, Sonia
dc.contributor.authorBarrús, María T
dc.contributor.authorSalaices, Mercedes
dc.contributor.authorAlonso, María J
dc.date.accessioned2024-06-04T07:27:15Z
dc.date.available2024-06-04T07:27:15Z
dc.date.issued2014-01-01
dc.description.abstractGlitazones have anti-inflamma-tory properties by interfering with the transcription of proinflamma-tory genes, such as cyclooxygenase (COX)-2, and with ROS produc-tion, which are increased in hypertension. This study analyzedwhether pioglitazone modulates COX-2 expression in hypertension byinterfering with ROS and endothelin (ET)-1. In vivo, pioglitazone (2.5mg·kg 1 ·day 1 , 28 days) reduced the greater levels of COX-2,pre-pro-ET-1, and NADPH oxidase (NOX) expression and activity aswell as O2· production found in aortas from spontaneously hyper-tensive rats (SHRs). ANG II increased COX-2 and pre-pro-ET-1levels more in cultured vascular smooth muscle cells from hyperten-sive rats compared with normotensive rats. The ETA receptor antag-onist BQ-123 reduced ANG II-induced COX-2 expression in SHRcells. ANG II also increased NOX-1 expression, NOX activity, andsuperoxide production in SHR cells; the selective NOX-1 inhibitorML-171 and catalase reduced ANG II-induced COX-2 and ET-1transcription. ANG II also increased c-Jun transcription and phospho-JNK1/2, phospho-c-Jun, and p65 NF- B subunit nuclear proteinexpression. SP-600125 and lactacystin, JNK and NF- B inhibitors,respectively, reduced ANG II-induced ET-1, COX-2, and NOX-1levels and NOX activity. Pioglitazone reduced the effects of ANG IIon NOX activity, NOX-1, pre-pro-ET-1, COX-2, and c-Jun mRNAlevels, JNK activation, and nuclear phospho-c-Jun and p65 expres-sion. In conclusion, ROS production and ET-1 are involved in ANGII-induced COX-2 expression in SHRs, explaining the greater COX-2expression observed in this strain. Furthermore, pioglitazone inhibitsANG II-induced COX-2 expression likely by interfering with NF- Band activator protein-1 proinflammatory pathways and downregulat-ing ROS production and ET-1 transcription, thus contributing to theanti-inflammatory properties of glitazones.es
dc.identifier.citationPioglitazone reduces angiotensin II-induced COX-2 expression through inhibition of ROS production and ET-1 transcription in vascular cells from spontaneously hypertensive rats Jose V. Pérez-Girón, Roberto Palacios, Angela Martín, Raquel Hernanz, Andrea Aguado, Sonia Martínez-Revelles, María T. Barrús, Mercedes Salaices, and María J. Alonso American Journal of Physiology-Heart and Circulatory Physiology 2014 306:11, H1582-H1593es
dc.identifier.doi10.1152/ajpheart.00924.2013es
dc.identifier.issn1522-1539 (online)
dc.identifier.issn0363-6135 (print)
dc.identifier.urihttps://hdl.handle.net/10115/33336
dc.language.isoenges
dc.publisherAmerican Physiological Societyes
dc.rights.accessRightsinfo:eu-repo/semantics/closedAccesses
dc.subjectangiotensin II; endothelin-1; reactive oxygen species; cyclooxygenase-2; hypertension; peroxisome proliferator-activated receptor-gammaes
dc.titlePioglitazone reduces angiotensin II-induced COX-2 expression through inhibition of ROS production and ET-1 transcription in vascular cells from spontaneously hypertensive ratses
dc.typeinfo:eu-repo/semantics/articlees

Archivos

Bloque original

Mostrando 1 - 1 de 1
No hay miniatura disponible
Nombre:
2014 AmJPhysiol-HeartCirc 306 H1582–H1593.pdf
Tamaño:
2.63 MB
Formato:
Adobe Portable Document Format
Descripción:

Bloque de licencias

Mostrando 1 - 1 de 1
No hay miniatura disponible
Nombre:
license.txt
Tamaño:
2.67 KB
Formato:
Item-specific license agreed upon to submission
Descripción: